SCHEMBL16619194

SCHEMBL16619194

OCc1cc2cc(C(F)(F)F)ccc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.45
HRH4 Q9H3N8 1/20 0.44
KIF11 P52732 6/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
AR P10275 1/20 0.39
KDM4E B2RXH2 1/20 0.38
KLKB1 P03952 1/20 0.38
MAP4K1 Q92918 1/20 0.38
LOXL2 Q9Y4K0 2/20 0.38
METAP2 P50579 1/20 0.38
RHEB Q15382 1/20 0.37
HDAC2 Q92769 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30042017 1.00 NR3C1 (0.45) NR3C1HRH4KIF11MEN1KMT2A
SCHEMBL23932536 0.86 METAP2 (0.45) NR3C1KIF11METAP2
SCHEMBL13365139 0.83 SCN10A (0.43) NR3C1KIF11LOXL2RHEB
SCHEMBL22996085 0.83 NR3C1 (0.45) NR3C1HRH4KIF11MEN1KMT2A
SCHEMBL17027129 0.78 F2 (0.55) NR3C1KIF11HDAC2
SCHEMBL5330339 0.77 KDM4E (0.51) NR3C1KDM4ERHEB
SCHEMBL27290612 0.77 HRH4 (0.47) HRH4KIF11MEN1KMT2AAR
SCHEMBL2216550 0.75 S1PR1 (0.46) NR3C1HRH4
SCHEMBL12096910 0.74 SRD5A2 (0.55) HRH4KLKB1MAP4K1HDAC2
SCHEMBL3529064 0.74 HRH4 (0.46) NR3C1HRH4ARKDM4EKLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-05-18 US disclosed
CN-115427404-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2022-12-02 CN disclosed
EP-3052495-B1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2019-06-26 EP disclosed
EP-3052495-B1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2019-06-26 EP disclosed
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2016-08-11 US disclosed
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2016-08-11 US disclosed
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2016-08-11 US disclosed
EP-3052495-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS Pfizer Inc. (US) 2016-08-10 EP disclosed
WO-2015049616-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER INC. (US) 2015-04-09 WO disclosed
WO-2015049616-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER INC. (US) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF COL1A1, COL2A1, COL14A1 NR3C1 994/4885HRH4 4471/4885KIF11 4444/4885
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS BACE1, BACE2, PSEN2 NR3C1 3310/4885HRH4 1480/4885KIF11 4539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.